E Trade Trust - No Fee International Index Fund (ETISX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD
11.35
-0.12 (-1.05%)
Jul 31, 2025, 9:30 AM EDT
-1.05%
Fund Assets20.36M
Expense Ration/a
Min. Investment$0.00
Turnovern/a
Dividend (ttm)n/a
Dividend Yieldn/a
Dividend Growthn/a
Payout Frequencyn/a
Ex-Dividend Daten/a
Previous Close11.47
YTD Returnn/a
1-Year Returnn/a
5-Year Returnn/a
52-Week Low10.22
52-Week High11.85
Beta (5Y)n/a
Holdings932
Inception Daten/a

About ETISX

The E*TRADE No Fee International Index Fund is an open-end mutual fund designed to provide investors with diversified exposure to companies domiciled in developed markets outside the United States. Managed by Morgan Stanley Investment Management, the fund’s primary objective is to closely track the performance of the Solactive GBS Developed Markets ex United States Large & Mid Cap USD Index NTR. This benchmark includes a broad range of large- and mid-cap equities across Europe, Asia-Pacific, and other developed regions, enabling investors to access international equities through a single investment vehicle. A notable feature of this fund is its 0% expense ratio and absence of commissions or investment minimums for E*TRADE clients, removing typical cost barriers and facilitating efficient international diversification. The fund generally holds hundreds of individual securities, including market leaders like SAP, Nestlé, ASML Holding, and Toyota Motor Corporation. As part of E*TRADE’s suite of no-fee index funds, it underscores a commitment to accessible, low-cost investing while leveraging the oversight and expertise of Morgan Stanley’s asset management division.

Fund Family Morgan Stanley
Stock Exchange NASDAQ
Ticker Symbol ETISX

Top 10 Holdings

15.33% of assets
NameSymbolWeight
Morgan Stanley & Co. LLC - Morgan Stanley Institutional Liquidity Funds - Government PortfolioMVRXX5.18%
SAP SESAP1.41%
Nestlé S.A.NESN1.33%
ASML Holding N.V.ASML1.23%
Roche Holding AGROG1.09%
Toyota Motor Corporation72031.05%
Novartis AGNOVN1.04%
AstraZeneca PLCAZN1.03%
Novo Nordisk A/SNOVO.B1.02%
HSBC Holdings plcHSBA0.95%